| |
Smoking habitsa
|
χ2 for trend
|
|---|
|
Neverb
|
Current
|
|---|
| |
<15 cig/day
|
≥15 cig/day
|
|---|
|
No.
|
No.
|
OR (95% CI)
|
No.
|
OR
|
95% CI
|
|---|
|
Non-Hodgkin lymphoma
|
|
Mature B-cell lymphomas
|
219
|
67
|
0.95 (0.67–1.34)
|
95
|
1.37 (0.97–1.92)
|
p = 0.09
|
|
DLBCL
|
133
|
33
|
0.76 (0.49–1.18)
|
49
|
1.09 (0.72–1.66)
|
p = 0.88
|
|
Burkitt
|
5
|
4
|
3.07 (0.74–12.81)
|
4
|
3.30 (0.71–15.28)
|
p = 0.16
|
|
Follicular
|
39
|
18
|
1.31 (0.69–2.47)
|
25
|
2.43 (1.31–4.51)
|
p < 0.01
|
|
Mantle cell
|
4
|
1
|
0.66 (0.07–6.41)
|
2
|
1.04 (0.17–6.50)
|
p = 0.99
|
|
Marginal zone
|
16
|
3
|
0.66 (0.18–2.44)
|
4
|
1.09 (0.33–3.66)
|
p = 0.80
|
|
Lymphoplasmacytic
|
8
|
3
|
1.56 (0.38–6.48)
|
2
|
0.87 (0.16–4.86)
|
p = 0.99
|
|
SLL/CLL
|
8
|
4
|
1.41 (0.40–4.93)
|
7
|
2.47 (0.81–7.59)
|
p = 0.06
|
|
Other B-cell lymphomas
|
6
|
1
|
0.45 (0.05–4.15)
|
2
|
2.87 (0.41–20.02)
|
p = 0.46
|
|
Mature T-cell lymphomas
|
14
|
8
|
1.83 (0.72–4.62)
|
6
|
1.72 (0.59–5.03)
|
p = 0.15
|
|
Other or NOS
|
6
|
3
|
1.20 (0.75–1.91)
|
7
|
2.30 (1.40–3.77)
|
p < 0.01
|
|
Hodgkin lymphoma
|
|
Nodular sclerosis
|
61
|
28
|
1.14 (0.61–2.12)
|
18
|
1.76 (0.78–3.98)
|
p = 0.23
|
|
Mixed cellularity
|
6
|
2
|
1.02 (0.16–6.66)
|
10
|
5.60 (1.31–23.97)
|
p = 0.03
|
|
Other or NOS
|
18
|
6
|
0.78 (0.27–2.21)
|
15
|
3.22 (1.15–9.04)
|
p = 0.06
|
- Odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression model adjusted for gender, age, study center, years of education, and place of birth
-
CLL Chronic lymphocytic leukemia, DLBCL Diffuse large B-cell lymphoma, NOS Not otherwise specified, SLL Small lymphocytic lymphoma
-
aFormer smokers excluded. bReference category
